Home > Resources > Whitepapers > You save 80% on the continuous purification of small molecules and biomolecules

You save 80% on the continuous purification of small molecules and biomolecules

April 30, 2019

Higher productivity at significantly lower costs with Simulated Moving Bed Chromatography (SMBC)

Spotlight

Drug Discovery Center of Innovation

The Drug Discovery Center of Innovation (DDCOI) provides pharmaceutical expertise and project management resources to accelerate the translation of discoveries into therapeutics. We offer a non-profit alternative to more traditional approaches to early drug development, with a focus on cost-efficient execution of development tasks, rather than the creation of infrastructure. Our deep pharmaceutical development experts establish and manage project plans, and provide end-to-end data analysis and troubleshooting to facilitate the creation of a successful application for IND and beyond.

OTHER WHITEPAPERS

BIOPHARMACEUTICAL INDUSTRY AND INTERRELATED BIOTECHNOLOGY ORGANIZATIONS

whitePaper | November 21, 2019

Our Accounting and Finance team has published an overview of the accounting and finance challenges facing the Biopharmaceutical industry and interrelated Biotechnology organizations.

Viral Vectors as a Gene Delivery Vehicle

whitePaper | August 5, 2022

The field of gene and cell therapy is experiencing a renaissance, with innovations in the use of viral vectors as a gene delivery vehicle being a key factor in the field’s growth.

A digital ecosystem for Clinical Trails

whitePaper | July 30, 2021

Clinical trials are complex, lengthy, and resource-inefficient. The clinical research industry is responsible for the delivery of medical solutions to society by systematically evaluating their safety and efficacy in humans during so-called clinical trials. As exemplified by the COVID-19 pandemic, a steady and efficient influx of vaccines, therapeutics, and other innovative medical solutions is critical for meeting society’s current and future medical needs. Unfortunately, the industry faces several persistent issues that make clinical trial operations overly complex, lengthy, and resource-inefficient.

Transforming cell & gene therapy manufacturing

whitePaper | February 25, 2022

Digitalization and automation promise a better way to streamline the transfer of cell and gene therapies from drug discovery – to commercial production.

Characterization and identification of glucuronide metabolites

whitePaper | April 21, 2023

This technical note demonstrates the comprehensive characterization and confident identification of glucuronide metabolites from hepatocyte incubations of midazolam. An orthogonal fragmentation mechanism was applied to generate diagnostic fragmentions for confident identification of glucuronide metabolites

More Whitepapers